Contents

Current Pharmaceutical Design, Volume 19 - Number 21

Editorial (Hot Topic: Achieving Current Goals in Prevention and Treatment of Vascular Disease: An Update)

, 19(21): 3749 - 3752

Alberico L. Catapano, Moses S. Elisaf, Matilda Florentin, Dimitri P. Mikhailidis and Michael S. Kostapanos


DOI: 10.2174/1381612811319210001




Which is the Optimal Antihypertensive Combination in Different Diseases, a Renin- Angiotensin-aldosterone System Inhibitor with a Diuretic or with a Calcium Channel Blocker?

, 19(21): 3753 - 3765

Nicoletta Riva and Gregory Y.H. Lip


DOI: 10.2174/13816128113199990299




Hydrochlorothiazide vs. Chlorthalidone as the Optimal Diuretic for the Management of Hypertension

, 19(21): 3766 - 3772

Konstantinos Tziomalos, Vassilios G. Athyros, Dimitri P. Mikhailidis and andAsterios Karagiannis


DOI: 10.2174/13816128113199990315




How Should We Treat Hypertension and Dyslipidemia in Patients with Prediabetes?

, 19(21): 3773 - 3787

Vasilios Tsimihodimos, Matilda Florentin and Moses S. Elisaf


DOI: 10.2174/13816128113199990304




Acute Ischemic Cerebrovascular Events on Antiplatelet Therapy: What is the Optimal Prevention Strategy?

, 19(21): 3788 - 3794

Haralampos Milionis and Patrik Michel


DOI: 10.2174/1381612811319210005




Antiplatelet Drug Resistance and Variability in Response: The Role of Antiplatelet Therapy Monitoring

, 19(21): 3795 - 3815

Udaya S. Tantry and Paul A. Gurbel


DOI: 10.2174/1381612811319210006




Anticoagulant Prevention in Patients with Atrial Fibrillation: Alternatives to Vitamin K Antagonists

, 19(21): 3816 - 3826

Dariusz Kozlowski, Szymon Budrejko, Grzegorz Raczak, Jacek Rysz and Maciej Banach


DOI: 10.2174/1381612811319210007




Inflammatory Biomarkers and Cardiovascular Risk Assessment. Current Knowledge and Future Perspectives

, 19(21): 3827 - 3840

Elisavet Moutzouri, Vasilis Tsimihodimos and Alexandros D. Tselepis


DOI: 10.2174/13816128113199990307




Treating High Density Lipoprotein Cholesterol (HDL-C): Quantity Versus Quality

, 19(21): 3841 - 3857

Angela Pirillo, Giuseppe Danilo Norata and Alberico Luigi Catapano


DOI: 10.2174/13816128113199990298




Combined Dyslipidemia: Should the Focus be LDL Cholesterol or Atherogenic Dyslipidemia?

, 19(21): 3858 - 3868

Manfredi Rizzo, Marcin Barylski, Ali A. Rizvi, Giuseppe Montalto, Dimitri P. Mikhailidis and Maciej Banach


DOI: 10.2174/13816128113199990324




PCSK9 Inhibition - A Novel Mechanism to Treat Lipid Disorders?

, 19(21): 3869 - 3877

Maciej Banach, Manfredi Rizzo, Milan Obradovic, Giuseppe Montalto, Jacek Rysz, Dimitri P. Mikhailidis and Esma R. Isenovic


DOI: 10.2174/13816128113199990303




A Rational Approach to Identify Inhibitors of Mycobacterium tuberculosis Enoyl Acyl Carrier Protein Reductase

, 19(21): 3878 - 3883

Mahesh T Chhabria, Kailash B Parmar and Pathik S Brahmkshatriya


DOI: 10.2174/1381612811319210012




Current Developments of Coumarin Compounds in Medicinal Chemistry

, 19(21): 3884 - 3930

Xin-Mei Peng, Guri L.V. Damu and Cheng- He Zhou


DOI: 10.2174/1381612811319210013




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science